| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/10/2010 | CN101666791A Ash-sealing pipe ash discharging device of fly ash monitoring system |
| 03/10/2010 | CN101666790A Method for analyzing adsorption of shepherds purse on copper ions |
| 03/10/2010 | CN100593721C Immunoassay method and kit for an early and simulataneous detection of biochemical markers in a patient's sample |
| 03/10/2010 | CN100593720C Measuring method and compensating method for expansion-contract coefficient in winding copper coated plate manufacturing process |
| 03/09/2010 | US7676442 Selection of features predictive of biological conditions using protein mass spectrographic data |
| 03/09/2010 | US7676346 System and a method for observing and predicting a physiological state of an animal |
| 03/09/2010 | US7676329 Method and system for processing multi-dimensional measurement data |
| 03/09/2010 | US7676328 Method for identifying cell-specific proteins |
| 03/09/2010 | US7675058 for immobilizing amine-containing materials to substrate |
| 03/09/2010 | US7674918 xanthene-derived fluorophore which may be covalently attached to a target molecule to form a complex, for use in cell analysis techniques, particularly pH measurement and analysis of kinetics of migration |
| 03/09/2010 | US7674908 1-isopropyl-1H-indazole-3-carboxylic acid {(1S,3R,5R)-8-[2-(4-acetylpiperazin-1-yl)-ethyl]8-azabicyclo[3.2.1]oct-3-yl}amide; improved pharmacokinetic, bioavailability; gastrointestinal disorders: irritable bowel syndrome (IBS), chronic constipation, dyspepsia; CNS behavioral, mood disorder |
| 03/09/2010 | US7674896 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA |
| 03/09/2010 | US7674888 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 03/09/2010 | US7674883 Hybridoma cell line for production of transmembrane protein with EGF-like and 2 follistatin-like domains 2 specific immunoglobulin conjugate for diagnosis and treatment of prostate cancer |
| 03/09/2010 | US7674774 Abuse-resistant amphetamine prodrugs |
| 03/09/2010 | US7674766 Mass spectrometry-based identification of proteins |
| 03/09/2010 | US7674752 Functional protein arrays |
| 03/09/2010 | US7674633 Biosensor |
| 03/09/2010 | US7674632 makes use of a plurality of separate subsets of calibration microparticles for generating a unique calibration curve for each and every individual human sample being tested; accurately measure bound analytes both quantitatively and semi-quantitatively in the presence of free unbound analytes |
| 03/09/2010 | US7674625 Method for determining improper manipulation of urine samples using marker compounds |
| 03/09/2010 | US7674624 Method for real-time determination of volume fractions of a production fluid in a hydrocarbon reservoir |
| 03/09/2010 | US7674623 Method of stabilizing human natriuretic peptides |
| 03/09/2010 | US7674622 Method for determination of nucleated red blood cells and leukocytes in a whole blood sample in an automated hematology analyzer |
| 03/09/2010 | US7674616 Device and method for measuring properties of a sample |
| 03/09/2010 | US7674615 for controlling fluid flow from a sample receiving pad into a lateral flow assay test strip; disposable cartridges |
| 03/09/2010 | US7674604 Using computer modeling to identify positions where cysteinal insertion will lock protein comprising integrin domain sequences into preferential configuration; directed protein evolution |
| 03/09/2010 | US7674603 a porous body having regions of differing pore size that are associated with different chromogens specific to enzymes produced by microorganisms; rapid detection and identification of food and water borne microorganisms; urinary tract infection |
| 03/09/2010 | US7674599 Methods of using antibodies to detect alpha-synuclein in fluid samples |
| 03/09/2010 | US7674598 Method for a fully automated monoclonal antibody-based extended differential |
| 03/09/2010 | US7674597 Drug screening; modulating amyloid beta -protein-mediated cell death using agents that interfere with the activity of FISH adaptor protein; neurodegenerative diseases |
| 03/09/2010 | US7674596 Transfected cell line and a method using the same for the high throughput screening for inhibitors of the T-type calcium channel alpha-1H |
| 03/09/2010 | US7674595 Solid state NMR method for screening cell membrane protein binding drug candidates |
| 03/09/2010 | US7674594 Drug screening; Inhibitors of thymol activation of ion channel TRPA1 can be used to prevent the objectionable taste of thymol in medical uses where taste limits acceptance such as mouthwash |
| 03/09/2010 | US7674593 Preparation method of biotinylated protein and detection method using the same |
| 03/09/2010 | US7674592 Methods for testing for the development of Huntington's disease |
| 03/09/2010 | US7674591 Methods of using antibodies to human IL-13bc for inhibiting IL-13 binding |
| 03/09/2010 | US7674590 Methods for diagnosing and for monitoring the treatment of recurrent spontaneous abortion |
| 03/09/2010 | US7674589 Methods for tissue analysis |
| 03/09/2010 | US7674588 Screening using polarization anisotropy in FRET emissions |
| 03/09/2010 | US7674587 Analyzing the hybridization intensities, by using oligonucleotide probes, which is complementary to target nucleic acid sequence, using principal component analysis; genetic engineering ; rapid efficient method for analyzing polymorphic or biallelic markers |
| 03/09/2010 | US7674586 Methods of identifying modulators of L-glutamate-gated chloride channel proteins from Rhipicephalus sanguineus |
| 03/09/2010 | US7674584 identifying and measuring the effect that an agent has upon modulating the binding of a test compound to a GPCR |
| 03/09/2010 | US7674580 Compositions and methods for the modulation of sphingolipid metabolism and/or signaling |
| 03/09/2010 | US7674579 Bioassay determining carboplatin and paclitaxel (Taxol) chemosensitivity of epithelial ovarian cancer cells, where measurements of caspase-3 activation are surrogate markers for activation of chemotherapy-induced programmed cell death |
| 03/09/2010 | US7674578 Methods of using sIP-10 to assess HCV clearance and/or response to interferon therapy |
| 03/09/2010 | US7674577 Diagnosis of human glycosylation disorders |
| 03/09/2010 | US7674463 Method of inhibiting angiogenesis by administration of a corticotropin releasing factor receptor 2 agonist |
| 03/09/2010 | US7674462 Transforming growth factor receptor specific immunoglobulin for use in diagnosis prvention and treatment of tumor disorders; immunotherapy |
| 03/09/2010 | US7674460 Compositions and methods for restoring sensitivity to treatment with HER2 antagonists |
| 03/09/2010 | US7674459 treatment of Interleukin13 dependent neoplastic disorders; high affinity to both glycosylated and non-glycosylated human IL13; do not bind mouse IL13, and neutralize human IL13 activity at an approximate molar ratio of 1:2 (MAb:IL13) |
| 03/09/2010 | US7674458 Lysyl oxidase-like 1 (LOXL1) and elastogenesis |
| 03/09/2010 | US7674447 carbon nanotubes as electrodes; for biopolymers such as DNA and RNA |
| 03/09/2010 | US7674431 Microfluidic devices having a reduced number of input and output connections |
| 03/09/2010 | US7674235 Method for determining concentration; a dialyser |
| 03/09/2010 | US7674232 Method and apparatus for penetrating tissue |
| 03/09/2010 | US7673618 Control system for internal combustion engine |
| 03/09/2010 | US7673500 Fluid monitoring apparatus and method |
| 03/09/2010 | CA2672018A1 System and method for measuring properties of extracted earth formation material using pulse neutron spectroscopy |
| 03/09/2010 | CA2510125C Process and device for producing reagent carriers having a binding capability |
| 03/09/2010 | CA2464198C Method and apparatus for the detection of the response of a sensing device |
| 03/09/2010 | CA2449925C Control solution packets and methods for calibrating bodily fluid sampling devices |
| 03/09/2010 | CA2445244C A motor driven sampling apparatus for material collection |
| 03/09/2010 | CA2431903C Apparatus and methods for analyzing and improving agricultural products |
| 03/09/2010 | CA2402955C Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 03/09/2010 | CA2382464C High-affinity choline transporter |
| 03/09/2010 | CA2342960C G protein-coupled receptor antagonists |
| 03/09/2010 | CA2331726C Modulation of molecular interaction sites on rna and other biomolecules |
| 03/09/2010 | CA2302881C Method for quantification of an analyte |
| 03/09/2010 | CA2300374C Rapid assay for simultaneous detection and differentiation of antibodies to hiv |
| 03/09/2010 | CA2264963C Protein markers for esophageal cancer |
| 03/09/2010 | CA2186846C Saliva assay method and device |
| 03/05/2010 | CA2679676A1 Monoclonal antibodies for neutralizing anthrax toxin |
| 03/04/2010 | WO2010025434A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 03/04/2010 | WO2010025424A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 03/04/2010 | WO2010025410A2 Screening method for identifying patients at risk of adverse hepatologic events |
| 03/04/2010 | WO2010025393A2 Protein biomarkers and methods for diagnosing kawasaki disease |
| 03/04/2010 | WO2010025364A2 A NOVEL LUCIFERASE REPORTER SYSTEM FOR NON-INVASIVE MONITORING OF NFkB ACTIVITY IN VITRO AND IN VIVO |
| 03/04/2010 | WO2010025303A1 Dosing and monitoring patients on nitrogen-scavenging drugs |
| 03/04/2010 | WO2010025302A2 Apparatus for and method of processing biological samples |
| 03/04/2010 | WO2010025254A1 Method for real time measurement of acrylamide in a food product |
| 03/04/2010 | WO2010025216A1 System and methods for measuring biomarker profiles |
| 03/04/2010 | WO2010025131A1 Bone mineral density ratios as a predictor of osteoarthritis |
| 03/04/2010 | WO2010024971A1 Shutter for preventing electrical shock in a test strip reader |
| 03/04/2010 | WO2010024889A1 Fiber-based biosensors for use in detecting the presence of a biologically active substance |
| 03/04/2010 | WO2010024776A1 Anln protein as an endocrine treatment predictive factor |
| 03/04/2010 | WO2010024524A2 Nano-scale biochip scanner |
| 03/04/2010 | WO2010024492A1 The measuring device of pain reaction for experimental animals |
| 03/04/2010 | WO2010024491A1 The clinical testing method for neuropathic pain, and a measuring device thereof |
| 03/04/2010 | WO2010024485A1 Apparatus and method for multiple immunoassays on a chip |
| 03/04/2010 | WO2010024446A1 Electrode member for specific detection of test substance using photocurrent |
| 03/04/2010 | WO2010024405A1 Ifn type-1 production inhibitor and method for searching for same |
| 03/04/2010 | WO2010024374A1 Method for detecting the drug effects of dna methylation-inhibitors |
| 03/04/2010 | WO2010024326A1 Method of manufacturing blood testing container, blood testing container, and spray device |
| 03/04/2010 | WO2010024325A1 Blood collection container |
| 03/04/2010 | WO2010024293A1 Set of anti-vasohibin monoclonal antibodies |
| 03/04/2010 | WO2010024289A1 Marker for detecting il-17-producing helper t cell, and method for detecting il-17-producing helter t cell |
| 03/04/2010 | WO2010024271A1 Modified anti-heparin/pf4 complex antibody and hit antibody standard |
| 03/04/2010 | WO2010024224A1 Urea concentration measurement method and urea concentration measurement apparatus |
| 03/04/2010 | WO2010024221A1 Method for screening for antiangiogenic agent, and method for screening for antiangiogenic signal gene |
| 03/04/2010 | WO2010024197A1 Microchip and blood analysis system |